The firm, a prolific backer of drug startups, will use the cash to back companies working on therapeutics, medical devices ...

A nonprofit incubator said it will take over a 33,000-square-foot building in Richmond, which also possesses manufacturing ...

Vor Bio, Korro Bio, Insitro and Rallybio revealed plans to lay off chunks of their respective workforces in the latest job ...

Vesicor Therapeutics, a San Gabriel-based biotech firm developing p53-based cancer treatments, is set to go public through a ...

NewLimit’s Series B raise adds fuel to Silicon Valley’s growing obsession with anti-aging science and biohacking immortality.

Latin America is no stranger to food tech innovation, as startups like Upcycling Solutions, Future Biome, Kresko RNAtech and ...

Tilt your stock portfolio toward biotech companies now and you could stand to make substantial profits in the near future. You can also find cost-effective stocks under $20 to trade daily on the ...

Texas A&M University debuted its $13 million state-of-the-art Animal Reproductive Biotech Center, located at the college’s ...

GEO-MVA Advancing as the Leading U.S.-Developed Mpox Vaccine Candidate ATLANTA, GA - April 24, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company ...

If these times have anything to say about it, the next Microsoft is coming from the biotech sector. Investors are moving in looking for profits, even putting companies without products on the map.

a British world-class company. Can a new wave of biotech start-ups produce a company which can grow into a world-beater, or will they suffer the same fate? Andrew McConaghie reports. Recent news ...

The firm, which has an office in Fort Washington, is developing a one-time gene therapy for heart failure patients.